Thus, NONRATT021972 siRNA treatment may block P2X7 activation in the DRG to inhibit the up-regulation of TNF-α and GFAP and to decrease the pain behaviors of type 2 diabetic rats. This evidence concerns the gene GFAP and type 2 diabetes mellitus.